Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin

AIM: Assess the pharmacodynamics of lixisenatide once daily (QD) versus liraglutide QD in type 2 diabetes insufficiently controlled on metformin. METHODS: In this 28-day, randomized, open-label, parallel-group, multicentre study (NCT01175473), patients (mean HbA1c 7.3%) received subcutaneous lixisen...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapitza, C, Forst, T, Coester, H-V, Poitiers, F, Ruus, P, Hincelin-Méry, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752965/
https://www.ncbi.nlm.nih.gov/pubmed/23368510
http://dx.doi.org/10.1111/dom.12076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752965/
https://www.ncbi.nlm.nih.gov/pubmed/23368510
http://dx.doi.org/10.1111/dom.12076

Ejemplares similares